他汀类药物对接受经皮冠状动脉介入治疗的血液透析患者主要不良心脏事件的影响。 - Suppr | 超能文献

Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis.

作者信息

Caturano Alfredo, Spiezia Serenella, Sasso Ferdinando Carlo

机构信息

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

出版信息

J Cardiovasc Pharmacol. 2022 Feb 1;79(2):155-156. doi: 10.1097/FJC.0000000000001170.

DOI:10.1097/FJC.0000000000001170

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis.他汀类药物对接受经皮冠状动脉介入治疗的血液透析患者主要不良心脏事件的影响。

J Cardiovasc Pharmacol. 2022 Feb 1;79(2):155-156. doi: 10.1097/FJC.0000000000001170.

2

Stratification Analysis of Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis.他汀类药物对接受经皮冠状动脉介入治疗的血液透析患者主要不良心脏事件影响的分层分析

J Cardiovasc Pharmacol. 2022 Feb 1;79(2):168-176. doi: 10.1097/FJC.0000000000001152.

3

Continuative statin therapy after percutaneous coronary intervention improves outcome in coronary bypass surgery: a propensity score analysis of 2501 patients.经皮冠状动脉介入治疗后继续他汀类药物治疗可改善冠状动脉搭桥手术的预后：对2501例患者的倾向评分分析

J Thorac Cardiovasc Surg. 2014 Nov;148(5):1876-83. doi: 10.1016/j.jtcvs.2014.02.045. Epub 2014 Feb 20.

4

Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.他汀类药物预处理对行经皮冠状动脉介入治疗患者的临床获益：13 项随机研究的患者水平荟萃分析。

Circulation. 2011 Apr 19;123(15):1622-32. doi: 10.1161/CIRCULATIONAHA.110.002451. Epub 2011 Apr 4.

5

Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry.他汀类药物对行经皮冠状动脉介入治疗的心力衰竭患者有益吗？来自墨尔本介入治疗组注册研究的结果。

Cardiovasc Drugs Ther. 2018 Feb;32(1):57-64. doi: 10.1007/s10557-018-6769-y.

6

High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.经皮冠状动脉介入治疗前大剂量他汀类药物负荷治疗可降低心血管事件：一项随机对照试验的荟萃分析

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):53-60. doi: 10.1002/ccd.25302. Epub 2013 Dec 21.

7

High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后 LDL-C 达标患者中高强度与非高强度他汀类药物的比较。

J Am Heart Assoc. 2018 Nov 6;7(21):e009517. doi: 10.1161/JAHA.118.009517.

8

Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: A nationwide retrospective cohort study.经皮冠状动脉介入治疗后接受慢性血液透析的患者中他汀类药物的有益作用：一项全国性回顾性队列研究。

Sci Rep. 2018 Jun 26;8(1):9692. doi: 10.1038/s41598-018-27941-w.

9

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.长期他汀类药物治疗对非紧急经皮冠状动脉介入治疗患者术后心肌梗死的影响。

Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2.

10

Effect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis.大剂量他汀类药物预处理对接受经皮冠状动脉介入治疗患者围手术期心肌梗死发生率的影响：通过累积荟萃分析对证据进行分级

Clin Cardiol. 2015 Nov;38(11):668-78. doi: 10.1002/clc.22471. Epub 2015 Oct 7.

引用本文的文献

1

The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.双重负担：探索慢性肾脏病中的心血管并发症。

Biomolecules. 2024 Oct 31;14(11):1393. doi: 10.3390/biom14111393.

2

Preexisting Cardiovascular Disease, Hypertension, and Mortality in Peritoneal Dialysis.腹膜透析患者的既往心血管疾病、高血压与死亡率

Rev Cardiovasc Med. 2023 Jan 16;24(1):30. doi: 10.31083/j.rcm2401030. eCollection 2023 Jan.